FDA 483 - Pharmaron Shaoxing Co., Ltd. - June 04, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Pharmaron Shaoxing Co., Ltd. in Shaoxing, China, revealed significant deficiencies in their quality control systems for API manufacturing. The firm failed to conduct adequate investigations into out-of-specification results, lacking sufficient evidence for root cause determination. Additionally, the company did not maintain proper backup files for computerized system data and lacked records for the cleaning and maintenance of manufacturing equipment.
ID · 543df91f-f20e-47b9-8b8a-1b7c422d5f05